Skip to content

Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer

COMET - Communication and Education in Tumor Profiling: A Randomized Study of Pre-Disclosure Genetic Education v. Usual Care in Tumor Profiling for Advanced Cancer and a Pilot Study of Remote Genetic Counseling for Participants With Potential Germline Mutations Identified on Tumor Profiling

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02823652
Enrollment
601
Registered
2016-07-06
Start date
2016-10-25
Completion date
2019-12-26
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Malignant Neoplasm, Locally Advanced Malignant Neoplasm

Brief summary

This research trial studies how well pre-test genetic education and remote genetic counseling works in communicating tumor profiling results to patients with advanced cancer. Web-based genetic education before receiving tumor profiling results and remote genetic counseling for patients with potential germline mutations may increase genetic knowledge and reduce distress for patients with advanced cancer.

Detailed description

PRIMARY OBJECTIVES: I. To evaluate the efficacy of web-based pre-disclosure genetic education (i.e. before receipt of tumor profile results) to increase knowledge (genetic knowledge and knowledge of test benefits and limitations). (Step 1) II. To evaluate the efficacy of web-based pre-disclosure genetic education (i.e. before receipt of tumor profile results) to decrease distress (anxiety, depression and cancer specific worry) compared to usual care services in patients undergoing tumor profiling for advanced cancer. (Step 1) III. To evaluate the uptake of remote genetic counseling (Step 2) IV. To evaluate the uptake of germline testing among advanced cancer patients with a potential clinically significant incidental germline mutation identified through tumor profiling in the Molecular Analysis for Therapy Choice (MATCH) trial. (Step 2) SECONDARY OBJECTIVES: I. To evaluate potential moderators suggested by the self-regulation theory of health behavior (SRTHB) (e.g. test result, sociodemographic factors, health literacy, baseline knowledge or distress) to changes in knowledge of genetic disease and test benefits and limitations. (Step 1) II. To evaluate potential moderators suggested by the SRTHB (e.g test result, sociodemographic factors, health literacy, baseline knowledge or distress) to changes in distress in patients undergoing tumor profiling for advanced cancer. (Step 1) III. To evaluate factors associated with uptake of genetic counseling and germline testing. (Step 2) IV. To evaluate cognitive, affective and behavioral (communication to relatives) responses to confirmatory germline testing in advanced cancer patients with potential clinically significant incidental germline mutation identified in tumor profiling. (Step 2) OUTLINE: STEP I (PRIMARY INTERVENTION STUDY): Participants are randomized to 1 of 2 arms. ARM A: Patients receive web-based genetic education consisting of general information about testing tumors for genetic mutations. ARM B: Patients receive standard genetic education consisting of conversations with the treating physicians, interaction with and information from the clinical staff, and information from usual resources about testing for genetic mutations. STEP II (SECONDARY GENETIC COUNSELING SUBSTUDY): Patients who meet the criteria for the remote counseling substudy will receive genetic counseling over the telephone and undergo germline testing. After completion of study treatment, patients are followed up periodically.

Interventions

OTHERstandard genetic education

Undergo usual care

OTHERGenetic Counseling

Complete remote counseling

OTHERGenetic Testing

Undergo germline testing

OTHERInternet-Based Intervention

Complete on-line genetic education

OTHERSurvey Administration

Ancillary studies

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
ECOG-ACRIN Cancer Research Group
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* (STEP 1) - PRIMARY INTERVENTION STUDY (RANDOMIZED CONTROLLED TRIAL \[RCT\]): * Patients must be registered to the first screening step (Step 0) for the National Cancer Institute (NCI)-MATCH trial (EAY131) * Patients must speak English and have an adequate ability to view a website (primary intervention study) * (STEP 2) - SECONDARY GENETIC COUNSELING SUBSTUDY: * Patients must have a potential germline mutation, as determined by the NCI-MATCH tumor profiling assay * Patients must be able to speak English and hear by phone

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Participants Who Complete Germline Testing in the Genetic Counseling Substudy (Step 2)Assessed at baseline at Step 2Among participants who registered in the genetic counseling substudy (Step 2), the proportion of participants who completed remote genetic counseling will be reported. The proportion is defined as the number of participants who completed remote genetic counseling divided by the number of participants who agreed to participate in the genetic counseling study.
Proportion of Participants Who Complete Remote Genetic Counseling in the Genetic Counseling Substudy (Step 2)Assessed at baseline at Step 2Among participants who registered in the genetic counseling substudy (Step 2), the proportion of participants who completed remote genetic counseling will be reported. The proportion is defined as the number of participants who completed remote genetic counseling divided by the number of participants who agreed to participate in the genetic counseling study.
Change of Scores on Cancer Genetic Knowledge Scale From Baseline to Post-genetic EducationAssessed at baseline and post-genetic education (about 1-2 weeks post-baseline)There are 14 items in the questionnaire of Cancer Genetic Knowledge Scale. The total score ranges between 14 and 70. Higher scores indicate more/better knowledge. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and compared between the two arms (arms A and B) at Step 1.
Change of Scores on Impact of Events Scale (IES) From Baseline to Post-genetic EducationAssessed at baseline and up to 14 days post-baselineThere are 14 items in the questionnaire of Impact of Events Scale (IES). The total score ranges between 0 and 70. Higher scores indicate more stress. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and compared between the two arms (arms A and B) at Step 1.
Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety From Baseline to Post-genetic EducationAssessed at baseline and post-genetic education (about 1-2 weeks post-baseline)There are 4 items in the PROMIS - Anxiety questionnaire. The total score ranges between 4 and 20. Higher scores indicate more anxiety. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and compared between the two arms (arms A and B) at Step 1.
Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression From Baseline to Post-genetic EducationAssessed at baseline and post-genetic education (about 1-2 weeks post-baseline)There are 4 items in the PROMIS - Depression questionnaire. The total score ranges between 4 and 20. Higher scores indicate more depression. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and compared between the two arms (arms A and B) at Step 1.

Secondary

MeasureTime frameDescription
Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety From Baseline to Post-genetic Education by Arm and SexAssessed at baseline and post-genetic education (about 1-2 weeks post-baseline)There are 4 items in the PROMIS - Anxiety questionnaire. The total score ranges between 4 and 20. Higher scores indicate more anxiety. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and interaction between arm and sex was evaluated.
Change of Scores on Cancer Genetic Knowledge Scale From Baseline to Post-genetic Education by Arm and SexAssessed at baseline and post-genetic education (about 1-2 weeks post-baseline)There are 14 items in the questionnaire of Cancer Genetic Knowledge Scale. The total score ranges between 14 and 70. Higher scores indicate more/better knowledge. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and interaction between arm and sex was evaluated.
Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression From Baseline to Post-genetic Education by Arm and SexAssessed at baseline and post-genetic education (about 1-2 weeks post-baseline)There are 4 items in the PROMIS - Depression questionnaire. The total score ranges between 4 and 20. Higher scores indicate more depression. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and interaction between arm and sex was evaluated.
Change of Scores on Impact of Events Scale (IES) From Baseline to Post-genetic Education by Arm and SexAssessed at baseline and post-genetic education (about 1-2 weeks post-baseline)There are 14 items in the questionnaire of Impact of Events Scale (IES). The total score ranges between 0 and 70. Higher scores indicate more stress. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and interaction between arm and sex was evaluated.

Other

MeasureTime frameDescription
Factors Associated With Uptake of Remote Genetic Counseling in the Genetic Counseling Substudy (Step 2)Assessed at baseline in Step 2The associations between patient characteristics and whether a patient receives genetic counseling will be evaluated.
Satisfaction and Regret/Disappointment Related to Genetic Counseling Service or Germline Genetic Test ResultsAssessed at baseline, within 3 days of remote genetic counseling, within 3 days of germline testing results received, and 3 months after germline testing results received in Step 2Satisfaction and regret/disappointment related to genetic counseling service or germline genetic test results will be evaluated
Behavioral Responses to Confirmatory Germline TestingAssessed at baseline, within 3 days of remote genetic counseling, within 3 days of germline testing results received, and 3 months after germline testing results received in Step 2Behavioral responses (communication to others) to confirmatory germline testing in advanced cancer patients with potential clinically significant incidental germline mutation identified in tumor profiling will be evaluated.
How to Better Deliver Tumor Genetic Test Results and Germline Information in the FutureAssessed at baseline, within 3 days of genetic test results received, within 3 days of germline testing results receivedHow to better deliver tumor genetic test results and germline information in the future will be evaluated.
Satisfaction and Regret/Disappointment Related to Tumor Genetic Test ResultsAssessed within 3 days of tumor test results receivedSatisfaction and regret/disappointment related to tumor genetic test results will be evaluated.
Cognitive and Affective Responses to Confirmatory Germline Testing (Step 2)Assessed at baseline, within 3 days of remote genetic counseling, within 3 days of germline testing results received, and 3 months after germline testing results received in Step 2Cognitive and affective responses to confirmatory germline testing in advanced cancer patients with potential clinically significant incidental germline mutation identified in tumor profiling will be evaluated.

Countries

United States

Participant flow

Recruitment details

A total of 601 patients were enrolled between October 25, 2016 and March 31, 2019.

Participants by arm

ArmCount
Arm A (Step 1: Internet-based Intervention; Step 2: Genetic Counseling Substudy)
Patients receive web-based genetic education consisting of general information about testing tumors for genetic mutations. Patients who meet the criteria for the remote counseling substudy will receive genetic counseling over the telephone and undergo germline testing in Step 2.
293
Arm B (Step 1: Usual Care Control; Step 2: Genetic Counseling Substudy)
Patients receive standard genetic education consisting of conversations with the treating physicians, interaction with and information from the clinical staff, and information from usual resources about testing for genetic mutations. Patients who meet the criteria for the remote counseling substudy will receive genetic counseling over the telephone and undergo germline testing in Step 2.
301
Arm C (Step 1: no Participation; Step 2: Genetic Counseling Substudy)
Patients who did not participate in the primary on-line genetic education study (Step 1) but meet the criteria for the remote counseling substudy. These patients will receive genetic counseling over the telephone and undergo germline testing in Step 2.
7
Total601

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Step 1: On-line Genetic Education StudyBaseline survey not done58647
Step 2: Genetic Counseling SubstudyIneligible200
Step 2: Genetic Counseling SubstudyOther221
Step 2: Genetic Counseling SubstudyWithdrawal by Subject201

Baseline characteristics

CharacteristicArm A (Step 1: Internet-based Intervention; Step 2: Genetic Counseling Substudy)Arm B (Step 1: Usual Care Control; Step 2: Genetic Counseling Substudy)Arm C (Step 1: no Participation; Step 2: Genetic Counseling Substudy)Total
Age, Continuous65 years65 years62 years65 years
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants6 Participants0 Participants8 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
286 Participants291 Participants6 Participants583 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
5 Participants4 Participants1 Participants10 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants0 Participants1 Participants
Race (NIH/OMB)
Asian
4 Participants3 Participants0 Participants7 Participants
Race (NIH/OMB)
Black or African American
12 Participants16 Participants1 Participants29 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants1 Participants0 Participants2 Participants
Race (NIH/OMB)
Unknown or Not Reported
6 Participants6 Participants0 Participants12 Participants
Race (NIH/OMB)
White
268 Participants274 Participants6 Participants548 Participants
Sex: Female, Male
Female
161 Participants168 Participants6 Participants335 Participants
Sex: Female, Male
Male
132 Participants133 Participants1 Participants266 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 00 / 0
other
Total, other adverse events
0 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 0

Outcome results

Primary

Change of Scores on Cancer Genetic Knowledge Scale From Baseline to Post-genetic Education

There are 14 items in the questionnaire of Cancer Genetic Knowledge Scale. The total score ranges between 14 and 70. Higher scores indicate more/better knowledge. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and compared between the two arms (arms A and B) at Step 1.

Time frame: Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)

Population: Eligible patients who completed both baseline and post-genetic education questionnaires were included in the analysis.

ArmMeasureValue (MEAN)Dispersion
Arm A (Step 1: Internet-based Intervention)Change of Scores on Cancer Genetic Knowledge Scale From Baseline to Post-genetic Education1.43 score on a scaleStandard Deviation 4.31
Arm B (Step 1: Usual Care Control)Change of Scores on Cancer Genetic Knowledge Scale From Baseline to Post-genetic Education-0.80 score on a scaleStandard Deviation 3.63
p-value: <0.0001t-test, 2 sided
Primary

Change of Scores on Impact of Events Scale (IES) From Baseline to Post-genetic Education

There are 14 items in the questionnaire of Impact of Events Scale (IES). The total score ranges between 0 and 70. Higher scores indicate more stress. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and compared between the two arms (arms A and B) at Step 1.

Time frame: Assessed at baseline and up to 14 days post-baseline

Population: Eligible patients who completed both baseline and post-genetic education questionnaires were included in the analysis.

ArmMeasureValue (MEAN)Dispersion
Arm A (Step 1: Internet-based Intervention)Change of Scores on Impact of Events Scale (IES) From Baseline to Post-genetic Education-1.79 score on a scaleStandard Deviation 9.43
Arm B (Step 1: Usual Care Control)Change of Scores on Impact of Events Scale (IES) From Baseline to Post-genetic Education-0.19 score on a scaleStandard Deviation 9.86
p-value: 0.11t-test, 2 sided
Primary

Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety From Baseline to Post-genetic Education

There are 4 items in the PROMIS - Anxiety questionnaire. The total score ranges between 4 and 20. Higher scores indicate more anxiety. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and compared between the two arms (arms A and B) at Step 1.

Time frame: Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)

Population: Eligible patients who completed both baseline and post-genetic education questionnaires were included in the analysis.

ArmMeasureValue (MEAN)Dispersion
Arm A (Step 1: Internet-based Intervention)Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety From Baseline to Post-genetic Education-0.32 score on a scaleStandard Deviation 2.33
Arm B (Step 1: Usual Care Control)Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety From Baseline to Post-genetic Education-0.55 score on a scaleStandard Deviation 2.24
p-value: 0.312t-test, 2 sided
Primary

Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression From Baseline to Post-genetic Education

There are 4 items in the PROMIS - Depression questionnaire. The total score ranges between 4 and 20. Higher scores indicate more depression. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and compared between the two arms (arms A and B) at Step 1.

Time frame: Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)

Population: Eligible patients who completed both baseline and post-genetic education questionnaires were included in the analysis.

ArmMeasureValue (MEAN)Dispersion
Arm A (Step 1: Internet-based Intervention)Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression From Baseline to Post-genetic Education0.23 score on a scaleStandard Deviation 2.36
Arm B (Step 1: Usual Care Control)Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression From Baseline to Post-genetic Education-0.30 score on a scaleStandard Deviation 2.48
p-value: 0.035t-test, 2 sided
Primary

Proportion of Participants Who Complete Germline Testing in the Genetic Counseling Substudy (Step 2)

Among participants who registered in the genetic counseling substudy (Step 2), the proportion of participants who completed remote genetic counseling will be reported. The proportion is defined as the number of participants who completed remote genetic counseling divided by the number of participants who agreed to participate in the genetic counseling study.

Time frame: Assessed at baseline at Step 2

Population: Eligible patients who agreed to participate in Step 2 genetic counseling substudy

ArmMeasureValue (NUMBER)
Arm A (Step 1: Internet-based Intervention)Proportion of Participants Who Complete Germline Testing in the Genetic Counseling Substudy (Step 2)0.43 Proportion of participants
Arm B (Step 1: Usual Care Control)Proportion of Participants Who Complete Germline Testing in the Genetic Counseling Substudy (Step 2)0.25 Proportion of participants
Arm C (Step 1: no Participation; Step 2: Genetic Counseling Substudy)Proportion of Participants Who Complete Germline Testing in the Genetic Counseling Substudy (Step 2)0.57 Proportion of participants
Primary

Proportion of Participants Who Complete Remote Genetic Counseling in the Genetic Counseling Substudy (Step 2)

Among participants who registered in the genetic counseling substudy (Step 2), the proportion of participants who completed remote genetic counseling will be reported. The proportion is defined as the number of participants who completed remote genetic counseling divided by the number of participants who agreed to participate in the genetic counseling study.

Time frame: Assessed at baseline at Step 2

Population: Eligible patients who agreed to participate in Step 2 genetic counseling substudy

ArmMeasureValue (NUMBER)
Arm A (Step 1: Internet-based Intervention)Proportion of Participants Who Complete Remote Genetic Counseling in the Genetic Counseling Substudy (Step 2)0.43 Proportion of participants
Arm B (Step 1: Usual Care Control)Proportion of Participants Who Complete Remote Genetic Counseling in the Genetic Counseling Substudy (Step 2)0.5 Proportion of participants
Arm C (Step 1: no Participation; Step 2: Genetic Counseling Substudy)Proportion of Participants Who Complete Remote Genetic Counseling in the Genetic Counseling Substudy (Step 2)0.71 Proportion of participants
Secondary

Change of Scores on Cancer Genetic Knowledge Scale From Baseline to Post-genetic Education by Arm and Sex

There are 14 items in the questionnaire of Cancer Genetic Knowledge Scale. The total score ranges between 14 and 70. Higher scores indicate more/better knowledge. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and interaction between arm and sex was evaluated.

Time frame: Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)

Population: Eligible patients who completed both baseline and post-genetic education questionnaires were included in the analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Arm A (Step 1: Internet-based Intervention)Change of Scores on Cancer Genetic Knowledge Scale From Baseline to Post-genetic Education by Arm and SexMale1.4 score on a scaleStandard Deviation 4
Arm A (Step 1: Internet-based Intervention)Change of Scores on Cancer Genetic Knowledge Scale From Baseline to Post-genetic Education by Arm and SexFemale1.5 score on a scaleStandard Deviation 4.5
Arm B (Step 1: Usual Care Control)Change of Scores on Cancer Genetic Knowledge Scale From Baseline to Post-genetic Education by Arm and SexMale-0.5 score on a scaleStandard Deviation 3.7
Arm B (Step 1: Usual Care Control)Change of Scores on Cancer Genetic Knowledge Scale From Baseline to Post-genetic Education by Arm and SexFemale-1.1 score on a scaleStandard Deviation 3.6
Secondary

Change of Scores on Impact of Events Scale (IES) From Baseline to Post-genetic Education by Arm and Sex

There are 14 items in the questionnaire of Impact of Events Scale (IES). The total score ranges between 0 and 70. Higher scores indicate more stress. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and interaction between arm and sex was evaluated.

Time frame: Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)

Population: Eligible patients who completed both baseline and post-genetic education questionnaires were included in the analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Arm A (Step 1: Internet-based Intervention)Change of Scores on Impact of Events Scale (IES) From Baseline to Post-genetic Education by Arm and SexMale-0.9 score on a scaleStandard Deviation 8.6
Arm A (Step 1: Internet-based Intervention)Change of Scores on Impact of Events Scale (IES) From Baseline to Post-genetic Education by Arm and SexFemale-2.4 score on a scaleStandard Deviation 10
Arm B (Step 1: Usual Care Control)Change of Scores on Impact of Events Scale (IES) From Baseline to Post-genetic Education by Arm and SexMale-1.5 score on a scaleStandard Deviation 10.3
Arm B (Step 1: Usual Care Control)Change of Scores on Impact of Events Scale (IES) From Baseline to Post-genetic Education by Arm and SexFemale0.9 score on a scaleStandard Deviation 9.4
Secondary

Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety From Baseline to Post-genetic Education by Arm and Sex

There are 4 items in the PROMIS - Anxiety questionnaire. The total score ranges between 4 and 20. Higher scores indicate more anxiety. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and interaction between arm and sex was evaluated.

Time frame: Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)

Population: Eligible patients who completed both baseline and post-genetic education questionnaires were included in the analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Arm A (Step 1: Internet-based Intervention)Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety From Baseline to Post-genetic Education by Arm and SexMale-0.3 score on a scaleStandard Deviation 2.4
Arm A (Step 1: Internet-based Intervention)Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety From Baseline to Post-genetic Education by Arm and SexFemale-0.3 score on a scaleStandard Deviation 2.3
Arm B (Step 1: Usual Care Control)Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety From Baseline to Post-genetic Education by Arm and SexMale-0.4 score on a scaleStandard Deviation 1.9
Arm B (Step 1: Usual Care Control)Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety From Baseline to Post-genetic Education by Arm and SexFemale-0.6 score on a scaleStandard Deviation 2.5
Secondary

Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression From Baseline to Post-genetic Education by Arm and Sex

There are 4 items in the PROMIS - Depression questionnaire. The total score ranges between 4 and 20. Higher scores indicate more depression. The questionnaire was administered at baseline and post-genetic education. The change of scores from baseline to post-genetic education were calculated and interaction between arm and sex was evaluated.

Time frame: Assessed at baseline and post-genetic education (about 1-2 weeks post-baseline)

Population: Eligible patients who completed both baseline and post-genetic education questionnaires were included in the analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Arm A (Step 1: Internet-based Intervention)Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression From Baseline to Post-genetic Education by Arm and SexMale0.2 score on a scaleStandard Deviation 2.5
Arm A (Step 1: Internet-based Intervention)Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression From Baseline to Post-genetic Education by Arm and SexFemale0.2 score on a scaleStandard Deviation 2.3
Arm B (Step 1: Usual Care Control)Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression From Baseline to Post-genetic Education by Arm and SexMale0 score on a scaleStandard Deviation 2.3
Arm B (Step 1: Usual Care Control)Change of Scores on Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression From Baseline to Post-genetic Education by Arm and SexFemale-0.6 score on a scaleStandard Deviation 2.6
Other Pre-specified

Behavioral Responses to Confirmatory Germline Testing

Behavioral responses (communication to others) to confirmatory germline testing in advanced cancer patients with potential clinically significant incidental germline mutation identified in tumor profiling will be evaluated.

Time frame: Assessed at baseline, within 3 days of remote genetic counseling, within 3 days of germline testing results received, and 3 months after germline testing results received in Step 2

Other Pre-specified

Cognitive and Affective Responses to Confirmatory Germline Testing (Step 2)

Cognitive and affective responses to confirmatory germline testing in advanced cancer patients with potential clinically significant incidental germline mutation identified in tumor profiling will be evaluated.

Time frame: Assessed at baseline, within 3 days of remote genetic counseling, within 3 days of germline testing results received, and 3 months after germline testing results received in Step 2

Other Pre-specified

Factors Associated With Uptake of Remote Genetic Counseling in the Genetic Counseling Substudy (Step 2)

The associations between patient characteristics and whether a patient receives genetic counseling will be evaluated.

Time frame: Assessed at baseline in Step 2

Other Pre-specified

How to Better Deliver Tumor Genetic Test Results and Germline Information in the Future

How to better deliver tumor genetic test results and germline information in the future will be evaluated.

Time frame: Assessed at baseline, within 3 days of genetic test results received, within 3 days of germline testing results received

Other Pre-specified

Satisfaction and Regret/Disappointment Related to Genetic Counseling Service or Germline Genetic Test Results

Satisfaction and regret/disappointment related to genetic counseling service or germline genetic test results will be evaluated

Time frame: Assessed at baseline, within 3 days of remote genetic counseling, within 3 days of germline testing results received, and 3 months after germline testing results received in Step 2

Other Pre-specified

Satisfaction and Regret/Disappointment Related to Tumor Genetic Test Results

Satisfaction and regret/disappointment related to tumor genetic test results will be evaluated.

Time frame: Assessed within 3 days of tumor test results received

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026